Wave Life Sciences (WVE) News Today → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free WVE Stock Alerts $6.18 +0.01 (+0.16%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 4:02 AM | marketbeat.com152,400 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Swiss National BankSwiss National Bank acquired a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 152,400 shares of the company's stock, valued at approximately $770,000. Swiss NationalJune 1 at 1:39 AM | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives Consensus Rating of "Moderate Buy" from AnalystsWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have given a buy recommendMay 30 at 3:35 PM | marketbeat.comM28 Capital Management LP Boosts Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)M28 Capital Management LP increased its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 4.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,373,413 shares of the company's stock afterMay 30 at 8:30 AM | globenewswire.comWave Life Sciences to Present at 2024 Jefferies Global Healthcare ConferenceMay 20, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Down 3.4% Wave Life Sciences (NASDAQ:WVE) Shares Down 3.4%May 17, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Stock Price Up 5.8%Wave Life Sciences (NASDAQ:WVE) Shares Up 5.8%May 15, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Gap Up to $5.84Wave Life Sciences (NASDAQ:WVE) Shares Gap Up to $5.84May 15, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Wave Life Sciences (WVE) and GoodRx Holdings (GDRX)May 15, 2024 | benzinga.comWAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)May 15, 2024 | markets.businessinsider.comBuy Rating on Wave Life Sciences: Promising Pipeline and Market PotentialMay 15, 2024 | msn.comWells Fargo Initiates Coverage of Wave Life Sciences (WVE) with Overweight RecommendationMay 15, 2024 | msn.comWells Fargo starts Wave Life Sciences at buy, cites valuationMay 15, 2024 | marketbeat.comWells Fargo & Company Initiates Coverage on Wave Life Sciences (NASDAQ:WVE)Wells Fargo & Company initiated coverage on Wave Life Sciences in a research report on Wednesday. They issued an "overweight" rating and a $11.00 target price for the company.May 12, 2024 | finance.yahoo.comWave Life Sciences Ltd. (NASDAQ:WVE) Just Reported First-Quarter Earnings And Analysts Are Lifting Their EstimatesMay 11, 2024 | markets.businessinsider.comBuy Rating Affirmed on Wave Life Sciences with Promising Obesity and AATD ProgramsMay 11, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Cut to "Hold" at StockNews.comStockNews.com lowered Wave Life Sciences from a "buy" rating to a "hold" rating in a research report on Friday.May 10, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Issues Quarterly Earnings Results, Misses Estimates By $0.06 EPSWave Life Sciences (NASDAQ:WVE - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by ($0.06). The business had revenue of $12.54 million for the quarter, compared to analyst estimates of $25.67 million. During the same quarter in the previous year, the business posted ($0.27) earnings per share.May 9, 2024 | msn.comWVE Stock Earnings: WAVE Life Sciences Misses EPS, Misses Revenue for Q1 2024May 9, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Gap Down to $5.85Wave Life Sciences (NASDAQ:WVE) Shares Gap Down to $5.85May 9, 2024 | globenewswire.comWave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 9, 2024 | globenewswire.comWave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific OfficerMay 7, 2024 | globenewswire.comWave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare ConferenceMay 6, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Down 6.2% Wave Life Sciences (NASDAQ:WVE) Trading Down 6.2%May 3, 2024 | marketbeat.comWave Life Sciences (WVE) Scheduled to Post Earnings on ThursdayWave Life Sciences (NASDAQ:WVE) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.May 2, 2024 | globenewswire.comWave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024May 1, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Up 5.5%Wave Life Sciences (NASDAQ:WVE) Shares Up 5.5%April 30, 2024 | globenewswire.comWave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)April 30, 2024 | forbes.comSecond Chance At Life Powers Woman To Develop Award-Winning Wave Energy TechnologyApril 26, 2024 | markets.businessinsider.comBuy Rating Affirmed: Strategic Partnerships and Clinical Milestones Propel Wave Life Sciences’ Growth PotentialApril 26, 2024 | msn.comPalm Springs Surf Club Wave Pool Once Again Non-OperationalApril 23, 2024 | globenewswire.comWave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA EditingApril 20, 2024 | investing.comWave Life Sciences Ltd (WVE)April 20, 2024 | yahoo.comSurfer Rides 93.73 Foot Wave. New Record for Biggest Ever?April 19, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Trading Up 4.2%Wave Life Sciences (NASDAQ:WVE) Shares Up 4.2%April 16, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Trading Down 4.9%Wave Life Sciences (NASDAQ:WVE) Trading Down 4.9%April 16, 2024 | money.usnews.comWave Life Sciences Ltd.April 13, 2024 | morningstar.comWAVE Life Sciences LtdApril 12, 2024 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Given Average Recommendation of "Moderate Buy" by BrokeragesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the companApril 10, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Trading Up 2.6%Wave Life Sciences (NASDAQ:WVE) Stock Price Up 2.6%April 7, 2024 | investing.comWave Life Sciences CFO sells shares worth over $96kApril 7, 2024 | insidertrades.comKyle Moran Sells 15,630 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) StockApril 5, 2024 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) CFO Kyle Moran Sells 15,630 SharesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) CFO Kyle Moran sold 15,630 shares of the company's stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $6.17, for a total transaction of $96,437.10. Following the completion of the transaction, the chief financial officer now directly owns 33,921 shares in the company, valued at approximately $209,292.57. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.April 4, 2024 | yahoo.com100 Foot Wave Season 1 Streaming: Watch & Stream Online via HBO MaxApril 3, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Down 3.5% Wave Life Sciences (NASDAQ:WVE) Stock Price Down 3.5%April 1, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Buy Rating on Wave Life Sciences (WVE)April 1, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Given Buy Rating at Truist FinancialTruist Financial restated a "buy" rating and issued a $17.00 price target on shares of Wave Life Sciences in a research report on Monday.March 27, 2024 | globenewswire.comWave Life Sciences to Present at Upcoming Investor ConferencesMarch 25, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Gap Up to $5.77Wave Life Sciences (NASDAQ:WVE) Shares Gap Up to $5.77March 23, 2024 | finance.yahoo.comBillionaire Paul Tudor Jones and Insiders Love These 10 StocksMarch 19, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Trading Up 4.6%Wave Life Sciences (NASDAQ:WVE) Trading 4.6% Higher Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… WVE Media Mentions By Week WVE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WVE News Sentiment▼1.150.76▲Average Medical News Sentiment WVE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WVE Articles This Week▼52▲WVE Articles Average Week Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: URGN News AKBA News RAPT News MRNS News XENE News CORT News FOLD News IDYA News PTCT News MOR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WVE) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.